Searches both Title and Fulltext content
Takes you to the requested Key Event
Clear Search Terms Clears search terms and filters

Showing 1776 to 1800 of 1907 Key Events

Clear Table Filters
ID Title Event Component Count Biological Organization Created At Last Updated AOPs
2276 Increased, protein expression of proprotein convertase subtilisin/kexin type 9 (PCSK9)
1 Cellular Nov 13, 2024 Feb 10, 2025 548: Activation, Pregnane-X receptor, NR1l2 leads to increased plasma low-density lipoprotein (LDL) cholesterol via increased PCSK9 protein expression
2277 Inhibition, aromatase activity in plasma
0 Tissue Nov 16, 2024 Nov 16, 2024 549: Aromatase inhibition leads to reproductive toxicity (including growth and developmental toxicity) in adult female zebrafish
2278 Increased LMNA Mutation
0 Molecular Nov 20, 2024 Dec 2, 2024 550: Increased LMNA gene mutation leading to heart failure
2279 Structural changes in lamin A/C
0 Cellular Nov 20, 2024 Nov 20, 2024 550: Increased LMNA gene mutation leading to heart failure
2280 Increased delay in heart electrical conduction
0 Organ Nov 20, 2024 Nov 26, 2024
2281 Increased uncoordinated cardiac contraction
0 Tissue Nov 20, 2024 Nov 26, 2024 552: Inhibiton of L-Type Calcium Channels leading to heart failure via QT interval prolongation and Torsades de Pointes (TdP)
2282 Cardiac ion channels blockade
0 Molecular Nov 21, 2024 Nov 21, 2024 519: Cardiac ion channels blockade leading to increased incidence of cardiovascular morbidity and mortality
2283 Increased the early premature depolarizations during repolarization
0 Cellular Nov 21, 2024 Nov 26, 2024
2284 Increased Intracellular cAMP Levels
0 Cellular Nov 21, 2024 Nov 21, 2024 554: β-adrenergic receptor agonists leading to arrhythmias.
2285 Increased the delayed and early afterdepolarizations
0 Cellular Nov 21, 2024 Nov 26, 2024 554: β-adrenergic receptor agonists leading to arrhythmias.
2286 Inhibition of Na⁺/K⁺-ATPase
0 Molecular Nov 21, 2024 Nov 21, 2024 None
2287 Impaired Sodium-Calcium Exchange
0 Cellular Nov 21, 2024 Nov 21, 2024 556: Decreased Na/K ATPase activity leading to heart failure
2288 Phosphodiesterase inhibition
0 Molecular Nov 22, 2024 Nov 22, 2024 558: Phosphodiesterase inhibition leading to heart failure
2289 Hyperphosphorylation of ryanodine receptor (RyR2)
0 Cellular Nov 22, 2024 Nov 22, 2024 558: Phosphodiesterase inhibition leading to heart failure
2290 Inhibition of Funny current (If)
0 Molecular Nov 22, 2024 Nov 22, 2024 560: Inhibition of Funny current (If) leading to Arrhythmias
2291 Slowed Heart Rate
0 Tissue Nov 22, 2024 Nov 25, 2024
2292 Altered Cardiac Electrical Conduction
0 Organ Nov 22, 2024 Nov 22, 2024
2293 Aromatase, induction
1 Molecular Nov 22, 2024 Feb 21, 2025 561: Aromatase induction leading to estrogen receptor alpha activation via increased estradiol
2294 Plasma estradiol, increased
1 Cellular Nov 22, 2024 Jan 29, 2026
2295 HCN Channel Inhibition
0 Molecular Nov 24, 2024 Nov 24, 2024 562: HCN Channel Inhibition leading to Arrhythmias
2296 Reduced Pacemaker Activity in SA Node
0 Cellular Nov 24, 2024 Nov 25, 2024 562: HCN Channel Inhibition leading to Arrhythmias
2297 Serum bile acid levels, Altered
0 Cellular Nov 25, 2024 Nov 25, 2024 None
2298 Decrease, intratesticular testosterone levels
1 Organ Dec 12, 2024 Jan 27, 2025
2299 Altered, Redox Homeostasis
1 Molecular Dec 24, 2024 Jan 20, 2025 564: DBDPE-induced inhibition of mitochondrial complex Ⅰ leading to population decline via neurotoxicity and metabotoxicity.
2300 Disruption, Glucolipid metabolism
2 Cellular Dec 24, 2024 Jan 20, 2025 564: DBDPE-induced inhibition of mitochondrial complex Ⅰ leading to population decline via neurotoxicity and metabotoxicity.